The heart is the most metabolically active organ in the human body, and cardiac metabolism
has been studied for decades. However, the bulk of studies have focused on animal models …

Many countries are facing the advent of super-aging societies, where sarcopenia and frailty
will become pertinent problems. The prevalence of comorbidities is a major problem in …

Background Mitochondrial ATP production requires a small electron carrier, coenzyme Q 10
(CoQ 10), which has been used as adjunctive therapy in patients with cardiovascular …

Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10),
and its supplementation has been proposed. The aim of this systematic review was to …

The ATP consumption in heart is very intensive to support muscle contraction and relaxation.
Mitochondrion is the power plant of the cell. Mitochondrial dysfunction has long been …

Evidence exists that heart failure (HF) has an overall impact of 1-2% in the global population
being often associated with comorbidities that contribute to increased disease prevalence …

Background and aim: A large number of recent studies have reported on the use of
antioxidants in patients with polycystic ovary syndrome (PCOS). This study aimed to …

Aluminum phosphide (ALP)-induced cardiotoxicity is a major cause of high mortality rates.
As there is no specific antidote, restoring cardiac hemodynamics is the cornerstone for …

Objective Effective interventions that might limit myocardial ischemia-reperfusion (I/R) injury
are still lacking. Coenzyme Q10 (CoQ10) may exert cardioprotective actions that reduce …

Pediatric heart failure (HF) is an important clinical condition with high morbidity and
mortality. Compared to adults, pediatric HF shows different etiologies characterized by …